2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

Evaluation of corneal parameters in patients with idiopathic REM Sleep Behavior Disorder

S. You, KT. Kim, J. Jun, YW. Cho (Daegu, Republic of Korea)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Evaluation of neuroprotection by human ENGRAILED-1 in a chronic AAV-hα-synuclein-A53T (AAV-A53T) rat model of Parkinson Disease

A. Prochiantz, G. Porras, A. Simonnet, E. Pioli, C. Friedel, E. Bézard, A. Bousseau (Paris, France)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Evaluation of Retinal Layers in Restless Legs Syndrome

N. Ongun, G. Ongun (Burdur, Turkey)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Evaluation of swallowing function by video-fluorography in patients with parkinsonism

S. Nogawa, Y. Chin, H. Kanke, R. Kawamura, T. Nakayama, K. Tokuoka, T. Furukawa (Tokyo, Japan)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Evidence of survival and integration of implanted autologous peripheral nerve graft in substantia nigra in a patient with Parkinson’s disease

DR. Ginjupally, G. Quintero, Z. Guduru, J. Gurwell, J. Slevin, A. Granholm, G. Gerhardt, C. van Horne (Denver, CO, USA)

Gene and Cell-Based Therapies  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Evolution of anti-parkinsonian drug prescribing patterns in Parkinson’s disease

S. Neo, A. Wong, HL. Ng, W. Li, KY. Tay, WL. Au, L. Tan (Singapore, Singapore)

Neuropharmacology  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Evolution of ataxia in risk persons for spinocerebellar ataxia (SCA)

H. Jacobi, S. Tezenas Dumontcel, T. Klockgether, O. The-Risca-Investigators (Bonn, Germany)

Ataxia  ·  Les Muses, Level 3

1:45pm-3:15pm

Exergame training in Early Onset Ataxia patients

R. Brandsma, I. Ganzevoort, M. Berg, ZT. Dominguez Vega, LD. Jelsma, MM. Schoemaker, NM. Maurits, CJC. Lamoth, DA. Sival (Groningen, Netherlands)

Ataxia  ·  Les Muses, Level 3

1:45pm-3:15pm

Expanding the Phenotype of KCNA2 Mutation: Tics and Stereotypies

J. Legacy, M. Burns, A. Elkouzi, W. Deeb, I. Malaty (Gainesville, FL, USA)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Exploring anti-hypertensives as possible disease modifying agents in Parkinson’s disease using artificial intelligence and epidemiology

N. Visanji, S. Hensley Alford, A. Lacoste, P. Madan, I. Buleje, Y. Han, S. Spangler, L. Kalia, C. Marras (Toronto, ON, Canada)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3